95 related articles for article (PubMed ID: 29507395)
1. Pan-cancer analysis of somatic mutations across 21 neuroendocrine tumor types.
Cao Y; Zhou W; Li L; Wang J; Gao Z; Jiang Y; Jiang X; Shan A; Bailey MH; Huang KL; Sun SQ; McLellan MD; Niu B; Wang W; Ding L; Ning G
Cell Res; 2018 May; 28(5):601-604. PubMed ID: 29507395
[No Abstract] [Full Text] [Related]
2. High throughput gene sequencing reveals altered landscape in DNA damage responses and chromatin remodeling in sporadic pancreatic neuroendocrine tumors.
Ji S; Yang W; Liu J; Zhao J; Chen L; Ni Q; Long J; Yu X
Pancreatology; 2018 Apr; 18(3):318-327. PubMed ID: 29395620
[TBL] [Abstract][Full Text] [Related]
3. Cancer. New epigenetic drivers of cancers.
Elsässer SJ; Allis CD; Lewis PW
Science; 2011 Mar; 331(6021):1145-6. PubMed ID: 21385704
[No Abstract] [Full Text] [Related]
4. The effects of chromatin organization on variation in mutation rates in the genome.
Makova KD; Hardison RC
Nat Rev Genet; 2015 Apr; 16(4):213-23. PubMed ID: 25732611
[TBL] [Abstract][Full Text] [Related]
5. Lack of mutations in EGFR in gastroenteropancreatic neuroendocrine tumors.
Gilbert JA; Lloyd RV; Ames MM
N Engl J Med; 2005 Jul; 353(2):209-10. PubMed ID: 16014895
[No Abstract] [Full Text] [Related]
6. Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum.
Niemeijer ND; Papathomas TG; Korpershoek E; de Krijger RR; Oudijk L; Morreau H; Bayley JP; Hes FJ; Jansen JC; Dinjens WN; Corssmit EP
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1386-93. PubMed ID: 26259135
[TBL] [Abstract][Full Text] [Related]
7. Comparison of neuroendocrine differentiation and KRAS/NRAS/BRAF/PIK3CA/TP53 mutation status in primary and metastatic colorectal cancer.
Kleist B; Kempa M; Novy M; Oberkanins C; Xu L; Li G; Loland C; Poetsch M
Int J Clin Exp Pathol; 2014; 7(9):5927-39. PubMed ID: 25337237
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of H3F3A, a chromatin remodeling gene in common solid tumors.
Je EM; Yoo NJ; Lee SH
APMIS; 2014 Jan; 122(1):81-2. PubMed ID: 23758177
[No Abstract] [Full Text] [Related]
9. Adenomatous polyposis coli gene involvement in ileal enterochromaffin cell neuroendocrine neoplasms.
Bottarelli L; Azzoni C; Pizzi S; D'Adda T; Silini EM; Bordi C; Rindi G
Hum Pathol; 2013 Dec; 44(12):2736-42. PubMed ID: 24139208
[TBL] [Abstract][Full Text] [Related]
10. Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung.
Marchetti A; Felicioni L; Pelosi G; Del Grammastro M; Fumagalli C; Sciarrotta M; Malatesta S; Chella A; Barassi F; Mucilli F; Camplese P; D'Antuono T; Sacco R; Buttitta F
Hum Mutat; 2008 May; 29(5):609-16. PubMed ID: 18293376
[TBL] [Abstract][Full Text] [Related]
11. Genetics of pancreatic neuroendocrine tumors: implications for the clinic.
Pea A; Hruban RH; Wood LD
Expert Rev Gastroenterol Hepatol; 2015; 9(11):1407-19. PubMed ID: 26413978
[TBL] [Abstract][Full Text] [Related]
12. RET proto-oncogene point mutations in sporadic neuroendocrine tumors.
Komminoth P; Roth J; Muletta-Feurer S; Saremaslani P; Seelentag WK; Heitz PU
J Clin Endocrinol Metab; 1996 Jun; 81(6):2041-6. PubMed ID: 8964826
[TBL] [Abstract][Full Text] [Related]
13. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors.
Crona J; Gustavsson T; Norlén O; Edfeldt K; Åkerström T; Westin G; Hellman P; Björklund P; Stålberg P
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1428-35. PubMed ID: 25586243
[TBL] [Abstract][Full Text] [Related]
14. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors.
Park C; Ha SY; Kim ST; Kim HC; Heo JS; Park YS; Lauwers G; Lee J; Kim KM
Oncotarget; 2016 Jan; 7(4):4024-35. PubMed ID: 26684240
[TBL] [Abstract][Full Text] [Related]
15. Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas.
Toledo RA; Qin Y; Cheng ZM; Gao Q; Iwata S; Silva GM; Prasad ML; Ocal IT; Rao S; Aronin N; Barontini M; Bruder J; Reddick RL; Chen Y; Aguiar RC; Dahia PL
Clin Cancer Res; 2016 May; 22(9):2301-10. PubMed ID: 26700204
[TBL] [Abstract][Full Text] [Related]
16. Somatic and germline mutations in NETs: Implications for their diagnosis and management.
Minnetti M; Grossman A
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):115-27. PubMed ID: 26971848
[TBL] [Abstract][Full Text] [Related]
17. Explaining cancer type specific mutations with transcriptomic and epigenomic features in normal tissues.
Tiong KL; Yeang CH
Sci Rep; 2018 Jul; 8(1):11456. PubMed ID: 30061703
[TBL] [Abstract][Full Text] [Related]
18. [Mutations in histone H3.3 and chromatin remodeling genes drive pediatric and young adult glioblastomas].
Khuong-Quang DA; Gerges N; Jabado N
Med Sci (Paris); 2012 Oct; 28(10):809-12. PubMed ID: 23067407
[No Abstract] [Full Text] [Related]
19. Genomic profile of appendiceal goblet cell carcinoid is distinct compared to appendiceal neuroendocrine tumor and conventional adenocarcinoma.
Wen KW; Grenert JP; Joseph NM; Shafizadeh N; Huang A; Hosseini M; Kakar S
Hum Pathol; 2018 Jul; 77():166-174. PubMed ID: 29634977
[TBL] [Abstract][Full Text] [Related]
20. Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors: Ruling Out a Suspect?
Delgado Verdugo A; Crona J; Maharjan R; Hellman P; Westin G; Björklund P
Horm Metab Res; 2015 Jun; 47(6):452-5. PubMed ID: 25354328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
